Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)

Clinical trial NCT00502788 · COMPLETED

Trial details

NCT number: NCT00502788
Sponsor: Carelon Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Thalassemia

Start date: 2003-05-01
Primary completion: 2006-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.